The ATM creates a persistent overhang that will pressure the stock, especially given the concurrent 424B5 filing. Monitor daily trading volumes for signs of active ATM sales. The company's positive clinical momentum (NANOPULSE-AF study) may provide a floor, but the capital raise signals ongoing cash burn.
Price Chart
Executive Summary
Pulse Biosciences entered into an equity distribution agreement with Mizuho Securities to sell up to $75 million of common stock in an at-the-market (ATM) offering. This ATM was filed on the same day as a 424B5 prospectus supplement for the same $75M facility, creating immediate dilution overhang. The company has a $2.6B market cap and positive clinical momentum, but the capital raise signals cash needs for its nPulse Cardiac Catheter system development.
Key Facts
- Pulse Biosciences entered an equity distribution agreement with Mizuho Securities USA LLC to sell up to $75,000,000 of common stock.
- The ATM offering allows sales at market prices; Mizuho receives up to 3.0% commission on gross proceeds.
- The filing is concurrent with a 424B5 prospectus supplement for the same $75M ATM facility, filed on the same day.
- Proceeds will fund clinical evaluations of the nPulse Cardiac Catheter system and other development activities.
- The company has a $2.6B market cap and recently completed a $65.5M warrant exercise.
Financial Impact
Up to $75 million in potential dilution from common stock sales at market prices.
Risk Factors
- Dilution from ATM sales at market prices.
- Potential for accelerated selling if the stock price weakens.
- Cash burn rate may be higher than expected, necessitating further capital raises.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-026351 |
| Exhibit: ex_1000005.htm | 0001437749-26-026351 |
| Document: plse20260806_8k.htm | 0001437749-26-026351 |
| Document: 0001437749-26-026351-index-headers.html | 0001437749-26-026351 |
| Document: 0001437749-26-026351-index.html | 0001437749-26-026351 |
| Document: 0001437749-26-026351.txt | 0001437749-26-026351 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 8-K | $46.32 | awaiting T+60 | — | $53.03 (+14.49%) |
Oct 7, 2026 19d ago | 8-K | $49.09 | awaiting T+60 | — | $53.03 (+8.03%) |
Sep 15, 2026 5w ago | 8-K | $55.20 | awaiting T+60 | — | $53.03 (−3.93%) |
Aug 6, 2026 11w ago | 8-K | $42.41 | awaiting T+60 | — | $53.03 (−25.04%) |
Aug 6, 2026 11w ago | 424B5 | $42.41 | awaiting T+60 | — | $53.03 (−25.04%) |
Jul 29, 2026 12w ago | 8-K | $34.25 $52.68 | ▲ +53.81% | ▲ +49.08% | $53.03 (+54.83%) |
Jun 12, 2026 19w ago | Institutional Cluster | $24.37 $48.79 | ▲ +100.21% | ▲ +96.94% | $53.03 (+117.60%) |
Jun 10, 2026 19w ago | 8-K | $24.99 $54.71 | ▲ +118.93% | ▲ +112.35% | $53.03 (+112.20%) |
May 15, 2026 23w ago | Insider Cluster | $25.61 $43.32 | ▲ +69.15% | ▲ +64.30% | $53.03 (+107.07%) |
May 11, 2026 24w ago | Insider Cluster | $19.08 $37.90 | ▲ +98.64% | ▲ +94.24% | $53.03 (+177.94%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers